在7年的随访期间,老年抑郁量表得分的变化与身体表现,炎症状态和海马缩有关:来自Pro.V.A.的数据. 研究研究研究研究研究
Chiara Ceolin1, Caterina Trevisan2, Marianna Noale3
1Department of Medicine (DIMED), University of Padua, Padua, Italy; Geriatric Unit, University Hospital of Padua, Padua, Italy; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Aging Research Center, Stockholm, Sweden.
International psychogeriatrics
|October 17, 2025
概括
身体表现,如步行速度和椅子站测试,与老年人的抑郁症得分有关. 监测身体功能可能有助于改善心理健康和针对老年抑郁症的干预措施.
科学领域:
- 老年医学 老年医学
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 老年人的抑郁症往往表现出微妙的症状,导致诊断不足.
- 身体性能测试可以作为客观的健康标志物来探索心身联系.
- 调查身体功能与心理健康之间的关系对于老龄化人口至关重要.
研究的目的:
- 为了检查老年抑郁量表 (GDS) 评分的7年变化.
- 评估身体表现和GDS随时间变化之间的关联.
- 探索这种关系中的潜在的性别差异.
主要方法:
- 利用了来自Progetto Veneto Anziani研究的数据 (N=1429,年龄≥65).
- 收集了基线和7年后的身体表现数据 (握手,步行速度,椅子站),GDS和炎症标志物.
- 采用线性混合模型来分析与身体表现相对的GDS变化,包括对性别和海马体缩 (MRI) 的子组分析.
主要成果:
- 基线物理性能测量与GDS得分相关,独立于炎症.
- 在7年内,更高的步行速度和较差的椅子站性能与更高的GDS分数相关.
- 椅子站测试仍然是两性GDS的重要预测指标. 随着时间的推移,海马缩影响了身体表现和GDS之间的关系,特别是在女性中.
结论:
- 身体表现指标与老年抑郁症评分在老年人中显著相关.
- 椅子站测试成为跨性别和与海马缩相关的抑郁症状的一致指标.
- 监测身体功能代表了一种潜在的干预途径,以提高老年人群的心理健康.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
185
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
185
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


